ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
iSpecimen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.91−0.01 (-0.75%)
Close on Oct 19, 2026
- Market cap
- $1.27M
- P/E (TTM)
- –
- Dividend yield
- –
iSpecimen Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Specimens - contracts with customers [Member] | $1.74M | $9.10M | $9.36M | $9.96M | $10.94M | $8.09M | 89.9% | -80.9% |
| Shipping and other [Member] | $194.00K | $186.17K | $566.46K | $445.72K | $191.05K | $97.78K | 10.1% | +4.2% |
By region
From the segment and revenue-disaggregation notes of iSpecimen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.